González-Berríos Nereida
Department of Psychiatry, UPR School of Medicine, Medical Science Campus.
Bol Asoc Med P R. 2009 Jan-Mar;101(1):59-60.
Selective Serotonin Reuptake Inhibitors are the treatment of choice for depression and anxiety disorders due to its tolerability, safety and side effects profile. However, with the current and frequent use of these medications in patients with these disorders, new side effects have been reported. This case report describes the development of panic attacks in a 24-year-old-female patient with depressive and anxiety symptoms, and no previous predisposing history for panic attacks.
选择性5-羟色胺再摄取抑制剂因其耐受性、安全性和副作用情况，是治疗抑郁症和焦虑症的首选药物。然而，随着这些药物在患有这些疾病的患者中目前的频繁使用，已有新的副作用被报道。本病例报告描述了一名24岁有抑郁和焦虑症状且既往无惊恐发作易感史的女性患者发生惊恐发作的情况。
